Supplemental Oxygen therapy and Non-Invasive Ventilation in Corona Virus Disease (COVID-19)

authors:

avatar Soudeh Tabashi ORCID 1 , * , avatar Alireza Mirkheshti 1 , avatar Mastaneh Dahi Taleghani ORCID 1 , avatar Dariush Abtahi , avatar Maryam Vosoughian ORCID 1 , avatar Shahram Sayadi ORCID 1 , avatar Mohammadreza Moshari 1 , avatar Elham Memary ORCID 1 , avatar Shideh Dabir 1 , avatar Sohrab Salimi ORCID 1 , avatar Ardeshir Tajbakhsh ORCID 1

Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Journal of Cellular & Molecular Anesthesia: Vol.5, issue 1; e149603
article type: Review
DOI: https://doi.org/10.22037/jcma.v5i1.29689

how to cite: Tabashi S, Mirkheshti A, Dahi Taleghani M, Abtahi D, Vosoughian M, et al. Supplemental Oxygen therapy and Non-Invasive Ventilation in Corona Virus Disease (COVID-19). J Cell Mol Anesth. 2020;5(1):e149603. https://doi.org/10.22037/jcma.v5i1.29689.

Abstract

The world has experienced a pandemic due to novel Severe Acute Respiratory Disease Corona Virus-2 (SARS-CoV2) since December 2019. The clinical spectrum of the disease known as Coronavirus Disease 2019 (COVID-19) is so much wide, starting from an asymptomatic state to paucisymptomatic clinical presentation, pneumonia, respiratory failure to even death. Supplemental oxygen therapy is essential in managing COVID-19. Also, there is sparse evidence regarding use of non-invasive ventilation (NIV) in pandemics like SARS-CoV-2. This study reviews the currently available methods for respiratory support in COVID-19 with a discussion about using these modalieties in the COVID-19 pandemic.